$Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab$

Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab

Bibliographic Details
Main Authors:	Kalisa Lum, BS, Ruth Sanchez, BS, Cici Zhou, MD, Sophia Sangar, MD, Harry Dao, Jr., MD, Ashley Elsensohn, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	JAAD Case Reports
Subjects:	African American B-cell pseudolymphoma dupilumab therapy Type V skin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512624000584

Internet